04-Nov-2026 13:29:15
LALPATHLABGeneral news
DR LAL PATHLABS Q2 FY27 ; NET PROFIT UP 27% AT ₹194 CR (YOY), UP 14% (QOQ)
REVENUE UP 20% AT ₹874 CR (YOY), UP 10% (QOQ) EBITDA UP 25% AT ₹280 CR (YOY), UP 13% (QOQ) MARGINS AT 32.1% VS 30.7% (YOY), 31.0% (QOQ)
DR. LAL PATH LABS LTD.